Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money.
Today we look at two noteworthy recent insider buys.
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money.
Today we look at two noteworthy recent insider buys.
At Royal Caribbean Cruises, a filing with the SEC revealed that on Tuesday, Director Donald Thompson purchased 20,000 shares of RCL, at a cost of $48.63 each, for a total investment of $972,518.
So far Thompson is in the green, up about 10.8% on their buy based on today's trading high of $53.86.
Royal Caribbean Cruises is trading down about 1% on the day Thursday.
And at Inari Medical, there was insider buying on Wednesday, by Chief Medical Officer Thomas Tu who purchased 28,091 shares at a cost of $19.00 each, for a trade totaling $533,729.
Inari Medical is trading up about 1.4% on the day Thursday.
Tu was up about 130.5% on the buy at the high point of today's trading session, with NARI trading as high as $43.80 in trading on Thursday.